Elevated homocysteine levels: What inborn errors of metabolism might we be missing?
- PMID: 36271828
- DOI: 10.1002/ajmg.a.63001
Elevated homocysteine levels: What inborn errors of metabolism might we be missing?
Abstract
Elevated total plasma homocysteine (hyperhomocysteinemia) is a marker of cardiovascular, thrombotic, and neuropsychological disease. It has multiple causes, including the common nutritional vitamin B12 or folate deficiency. However, some rare but treatable, inborn errors of metabolism (IEM) characterized by hyperhomocysteinemia can be missed due to variable presentations and the lack of awareness. The aim of this study is to identify undiagnosed IEM in adults with significantly elevated homocysteine using key existing clinical data points, then IEM specific treatment can be offered to improve outcome. We conducted a retrospective study with data mining and chart review of patients with plasma total homocysteine >30 μmol/L over a two-year period. We offer biochemical and genetic testing to patients with significant hyperhomocysteinemia without a clear explanation to diagnose IEM. We identified 22 subjects with significant hyperhomocysteinemia but no clear explanation. Subsequently, we offered genetic testing to seven patients and diagnosed one patient with classic homocystinuria due to cystathionine beta-synthase deficiency. With treatment, she lowered her plasma homocysteine and improved her health. This study stresses the importance of a thorough investigation of hyperhomocysteinemia in adults to identify rare but treatable IEM. We propose a metabolic evaluation algorithm for elevated homocysteine levels.
Keywords: homocysteine; hyperhomocysteinemia; inborn errors; metabolism; thromboembolism; thrombophilia.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Hickey, S. E., Curry, C. J., & Toriello, H. V. (2013). ACMG practice guideline: Lack of evidence for MTHFR polymorphism testing. Genetics in Medicine, 15(2), 153-156. https://doi.org/10.1038/gim.2012.165
-
- Kožich, V., Sokolová, J., Morris, A. A. M., Pavlíková, M., Gleich, F., Kölker, S., Krijt, J., Dionisi-Vici, C., Baumgartner, M. R., Blom, H. J., & Huemer, M. (2021). Cystathionine β-synthase deficiency in the E-HOD registry-part I: Pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis. Journal of Inherited Metabolic Disease, 44(3), 677-692. https://doi.org/10.1002/jimd.12338
-
- Krijt, J., Kopecká, J., Hnízda, A., Moat, S., Kluijtmans, L. A., Mayne, P., & Kožich, V. (2011). Determination of cystathionine beta-synthase activity in human plasma by LC-MS/MS: Potential use in diagnosis of CBS deficiency. Journal of Inherited Metabolic Disease, 34(1), 49-55. https://doi.org/10.1007/s10545-010-9178-3
-
- Krijt, J., Sokolová, J., Šilhavý, J., Mlejnek, P., Kubovčiak, J., Liška, F., Malínská, H., Hüttl, M., Marková, I., Křížková, M., Stipanuk, M. H., Křížek, T., Ditroi, T., Nagy, P., Kožich, V., & Pravenec, M. (2021). High cysteine diet reduces insulin resistance in SHR-CRP rats. Physiological Research, 70(5), 687-700. https://doi.org/10.33549/physiolres.934736
-
- Levy, J., Rodriguez-Guéant, R. M., Oussalah, A., Jeannesson, E., Wahl, D., Ziuly, S., & Guéant, J. L. (2021). Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and/or inherited disorders of one-carbon metabolism: A 3.5-year retrospective cross-sectional study of consecutive patients. The American Journal of Clinical Nutrition, 113(5), 1157-1167. https://doi.org/10.1093/ajcn/nqaa432
MeSH terms
Substances
LinkOut - more resources
Full Text Sources